Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 56654 [E9-26286]
Download as PDF
<![CDATA[
56654
Federal Register / Vol. 74, No. 210 / Monday, November 2, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Centers for Disease Control and
Prevention
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSKHWCL6B1PROD with NOTICES
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Aging in Down
Syndrome Adults.
Date: November 9, 2009.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Norman Chang, PhD,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
(301) 496–1485, changn@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–26286 Filed 10–30–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
17:03 Oct 30, 2009
Jkt 220001
Subcommittee on Procedures
Reviews, Advisory Board on Radiation
and Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9:30 a.m.–5 p.m.,
November 17, 2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859)334–4611, Fax (859)334–
4619.
Status: Open to the public, but without a
public comment period. To access by
conference call, use the following
information 1(866)659–0537, Participant Pass
Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2011.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee on Procedures
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Reviews was established to aid the Advisory
Board in carrying out its duty to advise the
Secretary, HHS, on dose reconstruction. It is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Office of Compensation Analysis
and Support (OCAS) and its dose
reconstruction contractor.
Matters to be Discussed: The agenda for the
Subcommittee meeting includes: Discussion
of the following ORAU & OCAS procedures:
OTIB–013 (‘‘Special External Dose
Reconstruction Considerations for
Mallinckrodt Workers’’), OTIB–014 (‘‘Rocky
Flats Internal Dosimetry Co-Worker
Extension’’), OTIB–0029 (‘‘Internal Dosimetry
Co-Worker Data for Y–12’’), OTIB–0049
(‘‘Estimating Doses for Plutonium Strongly
Retained in the Lung’’), OTIB–0051 (‘‘Effect
of Threshold Energy and Angular Response
of NTA Film on Missed Neutron Dose at the
Oak Ridge Y–12 Facility’’), OTIB–0054
(‘‘Fission and Activation Product Assignment
for Internal Dose-Related Gross Beta and
Gross Gamma Analyses’’), and OTIB–0070
(‘‘Dose Reconstruction During Residual
Radioactivity Periods at Atomic Weapons
Employer Facilities’’); and a continuation of
the comment-resolution process for other
dose reconstruction procedures under review
by the Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public, but
without a public comment period. In the
event an individual wishes to provide
comments, written comments may be
submitted. Any written comments received
will be provided at the meeting and should
be submitted to the contact person below in
advance of the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, GA 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 27, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–26284 Filed 10–30–09; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 74, Number 210 (Monday, November 2, 2009)]
[Notices]
[Page 56654]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26286]
[[Page 56654]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Aging in Down Syndrome Adults.
Date: November 9, 2009.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852, (Telephone Conference Call)
Contact Person: Norman Chang, PhD, Scientific Review Officer,
Division of Scientific Review, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892, (301) 496-1485,
changn@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-26286 Filed 10-30-09; 8:45 am]
BILLING CODE 4140-01-P
